Monitoring healthy metabolic trajectories with nutritional metabonomics

Nutrients

Volumn 1, Issue 1, 2009, Pages 101-110

  Collino, Sebastiano ^a   Martin, François Pierre ^a   Kochhar, Sunil ^a   Rezzi, Serge ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

GC (Gas Chromatography); Gut microbiota; Metabolomics; Metabonomics; Metabotypes; MS (Mass Spectrometry); NMR (Nuclear Magnetic Resonance) spectroscopy; Nutrimetabonomics; Personalized nutrition; UPLC (Ultra Performance Liquid Chromatography)

Indexed keywords

FOOD ANALYSIS; GASTROINTESTINAL TRACT; HUMAN; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; METAGENOME; METHODOLOGY; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; PHYSIOLOGY; REVIEW;

FOOD ANALYSIS; GASTROINTESTINAL TRACT; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; METAGENOME; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 84861545036     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu1010101     Document Type: Review

References (44)

1. Bruce, S.J.; Tavazzi, I.; Parisod, V.; Rezzi, S.; Kochhar, S.; Guy, P.A. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal. Chem. 2009, 81, 3285-3296.
2. Skordi, E.; Yap, I.K.; Claus, S.P.; Martin, F.P.; Cloarec, O.; Lindberg, J.; Schuppe-Koistinen, I.; Holmes, E.; Nicholson, J.K. Analysis of time-related metabolic fluctuations induced by ethionine in the rat. J. Proteome. Res. 2007, 6, 4572-4581.
3. Yap, I.K.; Li, J.V.; Saric, J.; Martin, F.P.; Davies, H.; Wang, Y.; Wilson, I.D.; Nicholson, J.K.; Utzinger, J.; Marchesi, J.R.; Holmes E. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J. Proteome. Res. 2008, 7, 3718-3728.
4. Coen, M.; Lenz, E.M.; Nicholson, J.K.; Wilson, I.D.; Pognan, F.; Lindon, J.C. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 2003, 16, 295-303.
5. Coen, M.; Ruepp, S.U.; Lindon, J.C.; Nicholson, J.K.; Pognan, F.; Lenz, E.M.; Wilson, I.D. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J. Pharm. Biomed. Anal. 2004, 35, 93-105.
6. Waters, N.J.; Holmes, E.; Williams, C.M.; Waterfield, C.J.; Farrant, R.D.; Nicholson, J.K. NMR and Patter recognition studies on the time-related metabolic effects of alpha-Naphthylisothiocyanate on liver, urine and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol. 2001, 14, 1401-1412.
7. Beckwith-Hall, B.M.; Nicholson, J.K.; Nicholls, A.W.; Foxall, P.J.; Lindon, J.C.; Connor, S.C.; Abdi, M.; Connelly, J.; Holmes, E. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 1998, 11, 260-272.
8. Beckwith-Hall, B.M.; Thompson, N.A.; Nicholson, J.K.; Lindon, J.C.; Holmes, E. A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum. Analyst 2003, 128, 814-818.
9. Beckonert, O.; Bollard, E.; Ebbels, T.M.D.; Keun, H.C.; Antti, H.; Holmes, E.; Lindon, J.C.; Nicholson, J.K. NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches. Anal. Chim. Acta 2003, 490, 3-15.
10. Holmes, E.; Nicholson, J.K.; Nicholls, A.; Lindon, J.C.; Connor, S.C.; Polly, S.; Connelly, J. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemom. Intell. Lab. Syst. 1998, 44, 245-255.
11. Dunn, W.B.; Bailey, N.J.; Johnson, H.E. Measuring the metabolome: current analytical technologies. Analyst 2005, 130, 606-625.
12. Ellis, D.I.; Dunn, W.B.; Griffin, J.L.; Allwood, J.W.; Goodacre, R. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 2007, 8, 1243-1266.
13. Holmes, E.; Loo, R.L.; Stamler, J.; Bictash, M.; Yap, I.K.S.; Chan, Q.; Ebbels, T.; De Iorio, M.; Brown, I.J.; Veselkov, K.A.; Daviglus, M.L.; Kesteloot, H.; Ueshima, H.; Zhao, L.; Nicholson, J.K.; Elliott, P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453, 396-400.
14. Rezzi, S.; Martin, F.P.; Kochhar, S. Defining personal nutrition and metabolic health through metabonomics. Ernst. Schering Found. Symp. Proc. 2007, 4, 251-264.
15. Rezzi, S.; Ramadan, Z.; Martin, F.P.; Fay, L.B.; van, B.P.; Lindon, J.C.; Nicholson, J.K.; Kochhar, S. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J. Proteome. Res. 2007, 6, 4469-4477.
16. Rezzi, S.; Martin, F.P.; Shanmuganayagam, D.; Colman, R.J.; Nicholson, J.K.; Weindruch, R. Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates. Exp. Gerontol. 2009, 44, 356-362.
17. Makinen, V.P.; Forsblom, C.; Thorn, L.M.; Waden, J.; Gordin, D.; Heikkila, O.; Hietala, K.; Kyllonen, L.; Kyto, J.; Rosengard-Barlund, M.; Saraheimo, M.; Tolonen, N.; Parkkonen, M.; Kaski, K.; la-Korpela, M.; Groop, P.H. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes 2008, 57, 2480-2487.
18. Makinen, V.P.; Soininen, P.; Forsblom, C.; Parkkonen, M.; Ingman, P.; Kaski, K.; Groop, P.H.; la-Korpela, M. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol. Syst. Biol. 2008, 4, 167.
19. Martin, F.P.; Rezzi, S.; Philippe, D.; Tornier, L.; Messlik, A.; Holzlwimmer, G.; Baur, P.; Quintanilla-Fend, L.; Loh, G.; Blaut, M.; Blum, S.; Kochhar, S.; Haller, D. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J. Proteome. Res. 2009, 8, 2376-2387.
20. Martin, F.P.; Verdu, E.F.; Wang, Y.; Dumas, M.E.; Yap, I.K.; Cloarec, O.; Bergonzelli, G.E.; Corthesy-Theulaz, I.; Kochhar, S.; Holmes, E.;Lindon J.C.; Collins, S.M.; Nicholson, J.K. Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J. Proteome. Res. 2006, 5, 2185-2193.
21. Dunne, C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm. Bowel. Dis. 2001, 7, 136-145.
22. Gill, S.R.; Pop, M.; Deboy, R.T.; Eckburg, P.B.; Turnbaugh, P.J.; Samuel, B.S.; Gordon, J.I.; Relman, D.A.; Fraser-Liggett, C.M.; Nelson, K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312, 1355-1359.
23. Ley, R.; Turnbaugh, P.; Klein, S.; Gordon, J. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
24. Nicholson, J.K.; Holmes, E.; Wilson, I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3, 431-438.
25. Verdu, E.F.; Bercik, P.; Bergonzelli, G.E.; Huang, X.X.; Blennerhasset, P.; Rochat, F.; Fiaux, M.; Mansourian, R.; Corthesy-Theulaz, I.; Collins, S.M. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004, 127, 826-837.
26. Dethlefsen, L.; Fall-Ngai, M.; Relman, D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449, 811-818.
27. Bik, E.M.; Eckburg, P.B.; Gill, S.R.; Nelson, K.E.; Purdom, E.A.; Francois, F.; Perez-Perez, G.; Blaser, M.J.; Relman, D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. U S A 2006, 103, 732-737.
28. Eckburg, P.B.; Relman, D.A. The role of microbes in Crohn's disease. Clin. Infect. Dis. 2007, 44, 256-262.
29. Holmes, E.; Nicholson, J. Variation in gut microbiota strongly influences individual rodent phenotypes. Toxicol. Sci. 2005, 87, 1-2.
30. Dumas, M.E.; Barton, R.H.; Toye, A.; Cloarec, O.; Blancher, C.; Rothwell, A.; Fearnside, J.; Tatoud, R.; Blanc, V.; Lindon, J.C.; Mitchell, S.C.; Holmes, E.; McCarthy, M.I.; Scott, J.; Gauguier, D.; Nicholson, J.K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U S A 2006, 103, 12511-12516.
31. Lezama, R.; Diaz-Tellez, A.; Ramos-Mandujano, G.; Oropeza, L.; Pasantes-Morales, H. Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions. Neurochem. Res. 2005, 30, 1589-1597.
32. Turnbaugh, P.; Ley, R.; Mahowald, M.; Magrini, V.; Mardis, E.; Gordon, J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027-1031.
33. Bjorksten, B.; Sepp, E.; Julge, K.; Voor, T.; Mikelsaar, M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, 108, 516-520.
34. Warren, J.R. Gastric pathology associated with Helicobacter pylori. Gastroenterol. Clin. North Am. 2000, 29, 705-751.
35. Marshall, B. Helicobacter pylori: past, present and future. Keio J. Med. 2003, 52, 80-85.
36. Pereira, S.; Marliss, E.B.; Morais, J.A.; Chevalier, S.; Gougeon, R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008, 57, 56-63.
37. Gupta, P.; Andrew, H.; Kirschner, B.S.; Guandalini, S. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 2000, 31, 453-457.
38. Sartor, R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126, 1620-1633.
39. Martin, F.P.; Dumas, M.E.; Wang, Y.; Legido-Quigley, C.; Yap, I.K.; Tang, H.; Zirah, S.; Murphy, G.M.; Cloarec, O.; Lindon, J.C.; Sprenger, N.; Fay, L.B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; Nicholson, J.K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 2007, 3, 112.
40. Martin, F.P.; Sprenger, N.; Yap, I.K.; Wang, Y.; Bibiloni, R.; Rochat, F.; Rezzi, S.; Cherbut, C.; Kochhar, S.; Lindon, J.C.; Holmes, E.; Nicholson, J.K. Panorganismal Gut Microbiome-Host Metabolic Crosstalk. J. Proteome. Res. 2009, 8, 2090-2105.
41. Martin, F.P.; Wang, Y.; Sprenger, N.; Yap, I.K.; Rezzi, S.; Ramadan, Z.; Pere-Trepat, E.; Rochat, F.; Cherbut, C.; van, B.P.; Fay, L.B.; Kochhar, S.; Lindon, J.C.; Holmes, E.; Nicholson, J.K. Topdown systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 2008, 4, 205.
42. Martin, F.P.; Wang, Y.; Sprenger, N.; Yap, I.K.; Lundstedt, T.; Lek, P.; Rezzi, S.; Ramadan, Z.; van Bladeren, P.; Fay, L.B.; Kochhar, S.; Lindon, J.C.; Holmes, E.; Nicholson, J.K. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 2008, 4, 157.
43. Collins, M.D.; Gibson, G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 1999, 69, 1052S-1057S.
44. Montoliu, I.; Martin, F.P.; Collino, S.; Rezzi, S.; Kochhar, S. Multivariate modeling strategy for intercompartmental analysis of tissue and plasma 1H NMR spectrotypes. J. Proteome. Res. 2009, 8, 2397-2406.